2348 On Other Exchanges
2348 is not on other exchanges.

Executive Profile*

Kei Ling Li

Co-Founder, Chairman, Chairman of Nomination Committee and Member of Remuneration Committee,Dawnrays Pharmaceutical Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2015


Ms. Kei Ling Li is a Co-Founder of Dawnrays Pharmaceutical Holdings Ltd., and served as its Chief Executive Officer since March 1, 2015 until April 18, 2016. Ms. Li served as Head of Corporate Development at Dawnrays Pharmaceutical Holdings Ltd., since March 1, 2015. She is responsible for the overall planning and implementation of corporate development, financial management and strategies formulation of the Dawnrays Pharmaceutical. Ms. Li has over 20 years of experience ...

Read Full Background

Corporate Headquarters*

CNT Tower
Wanchai, -- --

Hong Kong

Phone: --
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chairman of Nomination Committee and Member of Remuneration Committee


There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Total Annual CompensationCNY885,000

Stock Options*

All Other CompensationCNY18,000

Total Compensation*

Total Annual Cash CompensationCNY942,000
Total Short Term CompensationCNY885,000
Other Long Term CompensationCNY18,000
Total Calculated CompensationCNY942,000
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.